title: 5-HTTLPR rs25531A > G differentially influence paroxetine and fluvoxamine antidepressant efficacy: a randomized, controlled trial.
authors.forename: Masaki
authors.initials: M
authors.lastname: Kato
authors.forename: Shinpei
authors.initials: S
authors.lastname: Nonen
authors.forename: Alessandro
authors.initials: A
authors.lastname: Serretti
authors.forename: Shinji
authors.initials: S
authors.lastname: Tetsuo
authors.forename: Yoshiteru
authors.initials: Y
authors.lastname: Takekita
authors.forename: Junichi
authors.initials: J
authors.lastname: Azuma
authors.forename: Toshihiko
authors.initials: T
authors.lastname: Kinoshita
mesh_terms: D000704:Analysis of Variance; D000928:Antidepressive Agents / Q000627:therapeutic use*; D003863:Depression / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics / Q000523:psychology; D005260:Female; D016666:Fluvoxamine / Q000627:therapeutic use*; D005787:Gene Frequency; D005838:Genotype; D006801:Humans; D007564:Japan; D016015:Logistic Models; D008297:Male; D017374:Paroxetine / Q000627:therapeutic use*; D010597:Pharmacogenetics; D010641:Phenotype; D020641:Polymorphism, Single Nucleotide; D011569:Psychiatric Status Rating Scales; D050486:Serotonin Plasma Membrane Transport Proteins / Q000235:genetics*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000928:Antidepressive Agents; C493230:SLC6A4 protein, human; D050486:Serotonin Plasma Membrane Transport Proteins; D017374:Paroxetine; D016666:Fluvoxamine